Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxabact in Primary Hyperoxaluria
NCT01037231Phase 3Completed
- Sponsor
- OxThera AB
- Start
- Dec 2009
- Primary completion
- Jan 2011
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in Primary hyperoxaluria (PH) comparing Oxabact Arm with Placebo Arm (2 arms). Primary endpoint: Percentage change in urinary oxalate levels (molar oxalate to creatinine ratio) from Baseline to Week 24. Started Dec 2009; status: completed.
02
Drugs
oxalobacter formigenes
03
Conditions
Primary hyperoxaluria (PH)
Beyond the preview
Go deeper on NCT01037231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01037231.